News
The FDA and other HHS agencies of interest to the pharma sphere have seen President Donald Trump’s first 100 days as he ...
Pharmalittle: We’re reading about the FDA and revolving doors, a Novo win over compounders, and more
Scores of FDA employees are searching for an exit from an agency in turmoil, especially staffers tasked with reviewing drug ...
Following massive layoffs and cuts at the FDA, Makary’s plan for the agency is yet to fully unfold. But he has hinted at what ...
The U.S. Food and Drug Administration's mass layoffs included senior negotiators in talks with the pharmaceutical industry ...
Big Pharma's M&A plans will likely take a hit if the U.S. government under the Trump administration lives up to its threats ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results